Moderna vaccine enters final stages of human trials
Biotechnology company Moderna will soon enter the final stage of human trials for their potential COVID-19 vaccine. The trial is expected to conclude in late October, although early results should be available before then.
In a statement, the company announced they will enter Phase 3 of human testing on July 27. Phase 3 will involve 30 000 participants in the US, half of whom will receive the mRNA-1273 vaccine and the other half placebos. Their reactions will be monitored over two years to determine the efficacy of the vaccine. Preliminary results are expected to be available before October, when the study is expected to conclude.
Source: capetownetc.com
Comments